We previously reported that high levels of tyrosine kinase receptor (RTK) gene amplification of EGFR, HER2, FGFR2, or MET had protein overexpression and rarely showed other coexisting gene alterations using the next-generation sequencing (NGS) method for gastric cancer [50]. Here, ERBB2 is linked to gastric cancer.